Evaluation of the Effect of Remission Plasma on Untreated Patients With Burkitt's Lymphoma

Summary

In a controlled study, eight patients with untreated Burkitt's lymphoma were given plasma from patients with Burkitt's lymphoma in remission or from normal volunteers. Although the donor plasma was shown to have in vitro antibody activity, no evidence for in vivo antitumor activity was noted. This preliminary study does not confirm previous reports of in vivo antitumor activity in the plasma of patients with Burkitt's lymphoma.